NAPHAZOLINE\PHENIRAMINE: 2,037 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
2,037
Total FAERS Reports
2 (0.1%)
Deaths Reported
8
Hospitalizations
2,037
As Primary/Secondary Suspect
2
Life-Threatening
11
Disabilities
Active Ingredient: NAPHAZOLINE HYDROCHLORIDE\PHENIRAMINE MALEATE ·
First Report: 1995 · Latest Report: 20250919
What Are the Most Common NAPHAZOLINE\PHENIRAMINE Side Effects?
#1 Most Reported
Eye irritation
631 reports (31.0%)
#2 Most Reported
Mydriasis
353 reports (17.3%)
#3 Most Reported
Drug ineffective
324 reports (15.9%)
All NAPHAZOLINE\PHENIRAMINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Eye irritation | 631 | 31.0% | 0 | 0 |
| Mydriasis | 353 | 17.3% | 0 | 2 |
| Drug ineffective | 324 | 15.9% | 0 | 2 |
| Eye pain | 255 | 12.5% | 0 | 0 |
| Vision blurred | 201 | 9.9% | 0 | 3 |
| Product use in unapproved indication | 163 | 8.0% | 0 | 0 |
| Ocular hyperaemia | 135 | 6.6% | 0 | 0 |
| Therapeutic response unexpected | 94 | 4.6% | 0 | 0 |
| Eye pruritus | 90 | 4.4% | 0 | 1 |
| Expired product administered | 80 | 3.9% | 0 | 1 |
| Lacrimation increased | 60 | 3.0% | 0 | 0 |
| Therapeutic product effect incomplete | 57 | 2.8% | 0 | 1 |
| Visual impairment | 57 | 2.8% | 0 | 0 |
| Dry eye | 54 | 2.7% | 0 | 0 |
| Off label use | 53 | 2.6% | 0 | 0 |
| Eye swelling | 51 | 2.5% | 0 | 1 |
| Instillation site pain | 51 | 2.5% | 0 | 0 |
| Product quality issue | 49 | 2.4% | 0 | 0 |
| Wrong technique in product usage process | 45 | 2.2% | 0 | 0 |
| Condition aggravated | 33 | 1.6% | 0 | 0 |
Who Reports NAPHAZOLINE\PHENIRAMINE Side Effects? Age & Gender Data
Gender: 71.9% female, 28.1% male. Average age: 57.3 years. Most reports from: US. View detailed demographics →
Is NAPHAZOLINE\PHENIRAMINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 0 |
| 2012 | 1 | 0 | 0 |
| 2013 | 49 | 0 | 0 |
| 2014 | 64 | 0 | 0 |
| 2015 | 106 | 0 | 1 |
| 2016 | 113 | 0 | 0 |
| 2017 | 120 | 0 | 2 |
| 2018 | 67 | 0 | 0 |
| 2019 | 95 | 0 | 3 |
| 2020 | 61 | 0 | 0 |
| 2021 | 54 | 0 | 0 |
| 2022 | 38 | 0 | 0 |
| 2023 | 56 | 0 | 0 |
| 2024 | 44 | 0 | 0 |
| 2025 | 36 | 0 | 0 |
What Is NAPHAZOLINE\PHENIRAMINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 685 |
| Eye pruritus | 368 |
| Eye allergy | 320 |
| Ocular hyperaemia | 235 |
| Hypersensitivity | 192 |
| Dry eye | 134 |
| Eye irritation | 115 |
| Multiple allergies | 78 |
| Lacrimation increased | 46 |
| Seasonal allergy | 43 |
NAPHAZOLINE\PHENIRAMINE vs Alternatives: Which Is Safer?
NAPHAZOLINE\PHENIRAMINE vs NAPROXEN
NAPHAZOLINE\PHENIRAMINE vs NAPROXEN\NAPROXEN
NAPHAZOLINE\PHENIRAMINE vs NAPROXEN\PSEUDOEPHEDRINE
NAPHAZOLINE\PHENIRAMINE vs NAPROXEN\SUMATRIPTAN
NAPHAZOLINE\PHENIRAMINE vs NARATRIPTAN
NAPHAZOLINE\PHENIRAMINE vs NASONEX
NAPHAZOLINE\PHENIRAMINE vs NATALIZUMAB
NAPHAZOLINE\PHENIRAMINE vs NATALIZUMAB-SZTN
NAPHAZOLINE\PHENIRAMINE vs NATAMYCIN
NAPHAZOLINE\PHENIRAMINE vs NATEGLINIDE
Official FDA Label for NAPHAZOLINE\PHENIRAMINE
Official prescribing information from the FDA-approved drug label.